Methylene Blue Dosage Chart: How Many mg Per Day, by Body Weight

Methylene Blue Dosage Chart by Body Weight

The table below translates the 0.5–1 mg/kg range — the most commonly referenced in cognitive and mitochondrial research — into milligrams, millilitres of a 2% solution (20 mg/mL), and approximate drops.

Body Weight	Introductory (~0.1 mg/kg)	Low Range (0.5 mg/kg)	Standard Range (1 mg/kg)
50 kg (110 lb)	5 mg ~5 drops / 0.25 mL	25 mg ~25 drops / 1.25 mL	50 mg ~50 drops / 2.5 mL
60 kg (132 lb)	6 mg ~6 drops / 0.3 mL	30 mg ~30 drops / 1.5 mL	60 mg ~60 drops / 3.0 mL
70 kg (154 lb)	7 mg ~7 drops / 0.35 mL	35 mg ~35 drops / 1.75 mL	70 mg ~70 drops / 3.5 mL
80 kg (176 lb)	8 mg ~8 drops / 0.4 mL	40 mg ~40 drops / 2.0 mL	80 mg ~80 drops / 4.0 mL
90 kg (198 lb)	9 mg ~9 drops / 0.45 mL	45 mg ~45 drops / 2.25 mL	90 mg ~90 drops / 4.5 mL
100 kg (220 lb)	10 mg ~10 drops / 0.5 mL	50 mg ~50 drops / 2.5 mL	100 mg ~100 drops / 5.0 mL

With a 2% solution (20 mg/mL) and a standard dropper (~20 drops/mL), 1 drop ≈ 1 mg — making drops and milligrams roughly interchangeable as a quick reference. mL measurements via graduated syringe are more precise.
† Values are derived from published research dose ranges and provided for reference only. This is not medical advice or a recommendation to self-administer.

For stacking with caffeine, see methylene blue and caffeine timing.

For exercise-specific timing, see methylene blue and exercise.

For the mitochondrial mechanism behind these protocols, see how methylene blue works.

Important: Methylene blue has documented interactions with serotonergic medications (SSRIs, SNRIs, MAOIs). See methylene blue drug interactions before combining with any prescription medication.

Nothing in this article should be interpreted as medical advice or a recommendation to self-administer. Methylene blue is sold by Perfect Blue Labs for research and laboratory purposes. Anyone considering personal use should consult a qualified healthcare professional.

---

---

The Research Behind These Numbers

The dose ranges in the chart above are not arbitrary. They reflect the ranges most frequently examined in peer-reviewed research on methylene blue's cognitive and mitochondrial effects. The five studies below represent key data points in that literature.

Riha et al. (2005) — Dose-Dependent Memory and Brain Oxygen Consumption

Published in the European Journal of Pharmacology, this study examined how different doses of methylene blue affected memory and brain oxygen consumption in rats. At 4 mg/kg, the compound improved behavioral habituation and object memory recognition, while also increasing brain oxygen consumption at low concentrations. At doses of 50–100 mg/kg, motor activity was reduced, suggesting adverse effects at the high end. The study established the dose-dependent relationship that subsequent research built on. Riha et al., Eur J Pharmacol, 2005 → PubMed 15792783

Rojas, Bruchey & Gonzalez-Lima (2012) — Neurometabolic Mechanisms Review

This review in Progress in Neurobiology synthesized the mechanistic and dose-response evidence across multiple studies. The authors documented that methylene blue exhibits a hormetic dose-response pattern — low doses enhance memory and provide neuroprotection, while high doses produce inhibitory or toxic effects. At 1 mg/kg, spatial memory performance approximately doubled compared to controls. The review remains one of the most-cited overviews of the dose-response literature. Rojas et al., Prog Neurobiol, 2012 → PubMed 22067440

Rodriguez et al. (2016) — Human Randomized Controlled Trial with fMRI

Published in Radiology, this double-blinded, placebo-controlled trial administered 280 mg of oral USP-grade methylene blue (approximately 4 mg/kg for a 70 kg person) to 26 healthy adults. Neuroimaging showed increased fMRI activity in the insular cortex during sustained attention tasks, and in prefrontal, parietal, and occipital regions during memory tasks. Memory retrieval improved by 7% compared to placebo (p = .01). This is one of the few randomized human trials examining methylene blue at a specific oral mg/kg dose. Rodriguez et al., Radiology, 2016 → PMC5084971

Rodriguez et al. (2017) — Functional Connectivity in the Human Brain

A follow-on study in Brain Imaging and Behavior used the same 280 mg oral dose in 28 healthy adults and found enhanced resting-state functional connectivity in regions associated with working memory and visual-motor coordination, including strengthened hippocampal-cerebellar connectivity. The authors noted the dose was selected based on prior animal research suggesting optimal neurometabolic effects in the 4 mg/kg range. Rodriguez et al., Brain Imaging Behav, 2017 → PMC5018244

Deng et al. (2021) — Cognitive Protection in Surgical Patients

Published in the Journal of Clinical Anesthesia, this randomized controlled trial administered 2 mg/kg of intravenous methylene blue to 248 elderly patients undergoing major non-cardiac surgery. Postoperative delirium occurred in 7.3% of the methylene blue group versus 24.2% in controls. Early postoperative cognitive dysfunction at day 7 was 16.1% versus 40.2% in the control group. While intravenous rather than oral, this study contributes to the evidence base for methylene blue's effect on cognitive function at the 2 mg/kg level. Deng et al., J Clin Anesth, 2021 → PubMed 33091706

The Biphasic Dose-Response: Why More Is Not Better

One principle that appears consistently across the methylene blue literature is a biphasic, or hormetic, dose-response curve. At low concentrations, methylene blue acts as an electron shuttle in the mitochondrial respiratory chain, supporting cytochrome oxidase activity and cellular energy production. At high doses, this relationship inverts — the compound transitions from antioxidant to pro-oxidant behavior and can suppress the same enzyme activity it enhances at lower doses.

The practical implication documented across studies: doses above 4 mg/kg have shown diminishing returns, and doses above 10 mg/kg have been documented to inhibit mitochondrial function rather than support it. This is why the published cognitive literature concentrates almost exclusively on the 0.5–4 mg/kg range, and why community protocols generally operate in the lower half of that window.

How to Read the Chart: Calculating Your Reference Dose

A 2% methylene blue solution contains 20 mg per mL. The formula is straightforward:

• mg ÷ 20 = mL required
• Example: 70 mg ÷ 20 = 3.5 mL

To find the mg target from the chart, multiply body weight in kg by the dose factor (0.5 for the low range, 1.0 for the standard range). Research protocols use 1 mL oral syringes or graduated droppers for accuracy. Visual estimation introduces variability that compromises reproducibility.

How Many Drops Is Each Dose?

A standard dropper delivers approximately 20 drops per mL, which means each drop of a 2% methylene blue solution contains roughly 1 mg of methylene blue. Using that reference:

• 25 mg dose — approximately 25 drops (1.25 mL)
• 35 mg dose — approximately 35 drops (1.75 mL)
• 50 mg dose — approximately 50 drops (2.5 mL)
• 70 mg dose — approximately 70 drops (3.5 mL)

A note on accuracy: Drop size is not standardized — it varies with dropper tip diameter, bottle angle, and liquid viscosity. At the volumes typical of methylene blue protocols (1.5–3.5 mL), counting individual drops introduces meaningful variability. Graduated oral syringes are more precise for consistent measurement.

How Many Times Per Day — Cycling Patterns in the Literature

Research and community protocols rarely use methylene blue as a continuous daily supplement without breaks. The most commonly documented pattern is 5 days on, 2 days off — typically aligned with weekday/weekend schedules. The rationale: continuous daily administration may produce diminishing returns through pathway adaptation; periodic breaks help preserve the compound's effects.

Longer breaks of one full week every 4–6 weeks are also described in long-term protocols. Studies that describe a daily dose are typically referring to the dose per administration, not a cumulative daily total from multiple doses — most protocols involve a single morning administration.

Timing Documented in Published Protocols

• Morning administration is standard — methylene blue's mild stimulant properties can interfere with sleep when administered later in the day
• Food is generally optional — both fed and fasted administration appear in the literature; some sources note gentler GI tolerance with food
• Vitamin C separation is common — ascorbic acid can reduce methylene blue to its colorless leucomethylene form, potentially reducing bioavailability; separating by 1–2 hours is a common precautionary practice
• Afternoon doses are uncommon — most documented protocols concentrate administration before noon

Compounds Commonly Studied in Combination

• Red and near-infrared light therapy — the most documented combination. Both activate cytochrome c oxidase; see our article on methylene blue and red light therapy
• NAD+ precursors (NMN, NR) — work on overlapping mitochondrial pathways; see methylene blue vs NAD+ precursors
• Racetam-class compounds — appear in community protocols for combined cognitive effects
• Omega-3 fatty acids — referenced for neuronal membrane support alongside methylene blue's mitochondrial activity

Documented Contraindications

The published literature is consistent on the following exclusions. Methylene blue is contraindicated, and generally excluded from research protocols, in individuals who:

• Are taking SSRIs, SNRIs, or MAOIs — methylene blue inhibits monoamine oxidase and can cause serotonin syndrome in combination with serotonergic medications
• Have a glucose-6-phosphate dehydrogenase (G6PD) deficiency
• Are pregnant or breastfeeding
• Are taking other medications sensitive to MAO inhibition

Anyone on prescription medications should consult a qualified healthcare professional before any methylene blue exposure. For a full breakdown, see our article on methylene blue interactions with medications.

Why Concentration Accuracy Matters

Every dose calculation in this chart assumes the solution is accurately concentrated at 2% (20 mg/mL). A bottle labeled 2% that delivers a different concentration invalidates every calculation against the reference table — the mg-per-mL relationship is the foundation of accurate dosing. This is why published research uses pharmaceutical-grade material with verified concentration, and why accurate labeling is essential for any research context where reproducible dosing matters.

Perfect Blue Labs' 2% solution is made and bottled in Canada to consistent concentration standards, with clear labeling on every batch.

---

---